|
US2776926A
(en)
|
1955-08-04 |
1957-01-08 |
Eugene S Sharpe |
Preparation of alpha-ketoglutaric acid by serratia marcescens
|
|
US2917528A
(en)
|
1956-08-24 |
1959-12-15 |
Victor Chemical Works |
Alkanolaminealkanephosphonic acids and salts thereof
|
|
US2841616A
(en)
*
|
1956-10-30 |
1958-07-01 |
Campbell Soup Co |
Process for the recovery of alpha-ketoglutaric acid
|
|
US3875304A
(en)
|
1970-04-24 |
1975-04-01 |
Schlitz Brewing Co J |
Livestock feed composition and method of preparing the same
|
|
US4045585A
(en)
|
1976-05-19 |
1977-08-30 |
Decel Corporation |
Flavored animal food compositions
|
|
US6451341B1
(en)
|
1990-02-05 |
2002-09-17 |
Thomas J. Slaga |
Time release formulation of vitamins, minerals and other beneficial supplements
|
|
US5646187A
(en)
|
1992-05-20 |
1997-07-08 |
Ab Erik Vinnars |
Use of alpha-ketoglutarate
|
|
US6306430B1
(en)
|
1998-04-16 |
2001-10-23 |
The Iams Company |
Process for decreasing adiposity using vitamin a as a dietary supplement
|
|
US6905707B2
(en)
|
1998-05-28 |
2005-06-14 |
Medical Research Institute |
Controlled release arginine alpha ketoglutarate
|
|
CO5140079A1
(es)
|
1998-10-14 |
2002-03-22 |
Novartis Ag |
Composicion farmaceutica de liberacion sostenida y metodo para liberar un agente farmaceuticamente activo de liberacion sostenida y metodo para liberar un agente far- maceuticamente activo
|
|
US6649654B1
(en)
|
1999-11-23 |
2003-11-18 |
The Regents Of The University Of California |
Methods for identifying and using IKK inhibitors
|
|
US7169755B2
(en)
|
2000-12-20 |
2007-01-30 |
Alcon, Inc. |
Solution for removing cataracts via liquefracture
|
|
US20060216358A1
(en)
*
|
2003-05-07 |
2006-09-28 |
Christian Hansen |
Controlled release composition containing a strontium salt
|
|
PL368572A1
(en)
|
2004-06-17 |
2005-12-27 |
Sgp & Sons Ab |
Pharmaceutical compound for prevention and therapy of increased level of cholesterol, ldl and triglycerides as well as application of the pharmaceutical compound as an agent acting against atherosclerosis and used in circulatory system affections
|
|
US20090005437A1
(en)
|
2004-08-09 |
2009-01-01 |
Eyal Gottlieb |
Alpha-Ketoglutarates and Their Use as Therapeutic Agents
|
|
ES2510690T3
(es)
|
2004-12-17 |
2014-10-21 |
Alan B. Cash |
Método para extender la esperanza de vida y retrasar la aparición de enfermedad relacionada con la edad
|
|
US20060234250A1
(en)
|
2005-04-15 |
2006-10-19 |
Powers Ralph W Iii |
Methods of screening and compositions for life span modulators
|
|
WO2007001883A2
(en)
|
2005-06-20 |
2007-01-04 |
Accera, Inc. |
Method to reduce oxidative damage and improve mitochondrial efficiency
|
|
US20070105942A1
(en)
|
2005-11-08 |
2007-05-10 |
Heuer Marvin A |
Supplemental dietary composition for turning on anabolic switches in muscle, stimulating and/or optimizing protein synthesis, and/or potently signaling muscle building and/or growth via molecular pathways
|
|
US8367121B2
(en)
|
2005-11-23 |
2013-02-05 |
Florida A & M University |
Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease
|
|
PL379512A1
(pl)
|
2006-04-21 |
2007-10-29 |
Sgp & Sons Ab |
Nowe metody i ich zastosowanie
|
|
PL226695B1
(pl)
|
2006-07-03 |
2017-08-31 |
Danuta Kruszewska |
Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori
|
|
JP2010522190A
(ja)
|
2007-03-19 |
2010-07-01 |
メタプロテオミクス, エルエルシー |
骨及び関節の健康を助成するための方法と組成物
|
|
US20110039935A1
(en)
|
2007-07-02 |
2011-02-17 |
Entress Ab |
Use of pharmacologically active chemical compounds
|
|
EP2033623A1
(en)
|
2007-09-07 |
2009-03-11 |
Cutech S.R.L. |
Compositions comprising ornithine ketoglutarate (OKG)
|
|
JP5406643B2
(ja)
|
2008-09-22 |
2014-02-05 |
日本合成化学工業株式会社 |
α−オキソカルボン酸の金属塩の製造方法
|
|
CN101759553A
(zh)
|
2008-11-21 |
2010-06-30 |
扬子江药业集团北京海燕药业有限公司 |
α-酮酸钙的制备方法
|
|
DE102009016119A1
(de)
|
2009-04-03 |
2010-10-14 |
Evonik Degussa Gmbh |
Nahrungsergänzungsmittel enthaltend alpha-Ketosäuren zur Unterstützung der Diabetestherapie
|
|
WO2010118419A2
(en)
|
2009-04-10 |
2010-10-14 |
Haiyan Qi |
Novel anti-aging agents and methods to identify them
|
|
CN102481269B
(zh)
|
2009-05-11 |
2015-10-07 |
博格有限责任公司 |
包含辅酶q10的药物组合物及其制备方法
|
|
EP3120709A1
(en)
|
2009-05-28 |
2017-01-25 |
IAMS Europe B.V. |
Pet food in the form of a coated kibble
|
|
US9950019B2
(en)
|
2009-06-12 |
2018-04-24 |
Generex Pharmaceuticals, Inc. |
Compositions and methods for the prevention and treatment of brain diseases and conditions
|
|
PL2448577T3
(pl)
|
2009-06-30 |
2017-02-28 |
Derman Biomedicine Co. Ltd. |
Kompozycje zawierające berberynę lub jej analogi do leczenia trądziku różowatego lub chorób skóry związanych z zaczerwienieniem twarzy
|
|
WO2011060305A1
(en)
|
2009-11-12 |
2011-05-19 |
Nox Technologies, Inc. |
Potato skin compositions that lower cytosolic nadh level to mimic calorie restriction
|
|
WO2012114204A2
(en)
|
2011-02-15 |
2012-08-30 |
Ecole Polytechnique Federale De Lausanne (Epfl) Epfl-Tto |
Methods of treating mitochondrial dysfunction
|
|
JP2014512372A
(ja)
|
2011-04-18 |
2014-05-22 |
ネステク ソシエテ アノニム |
α−HICA及びエイコサペンタエン酸を含有する栄養組成物
|
|
WO2012174537A2
(en)
|
2011-06-16 |
2012-12-20 |
President And Fellows Of Harvard College |
Small molecule screening for mouse satellite cell proliferation
|
|
CN102586347B
(zh)
*
|
2012-03-06 |
2014-04-09 |
江南大学 |
一种两阶段pH控制高产a-酮戊二酸的方法
|
|
US9532997B2
(en)
|
2012-04-03 |
2017-01-03 |
Whitehead Institute For Biomedical Research |
Compositions and methods for promoting intestinal stem cell function
|
|
ITBO20120226A1
(it)
|
2012-04-24 |
2013-10-25 |
Alfa Wassermann Spa |
Composizioni comprendenti ornitina alfa-chetoglutarato, processi per il loro ottenimento e il loro uso.
|
|
JP6029058B2
(ja)
|
2012-09-14 |
2016-11-24 |
国立研究開発法人農業・食品産業技術総合研究機構 |
シュウ酸カルシウムを含む氷核活性剤
|
|
PL3398594T3
(pl)
|
2012-09-19 |
2024-11-04 |
Grespo Ab |
Kompozycje do ulepszenia funkcji mózgu
|
|
CA2896646A1
(en)
|
2012-12-27 |
2014-07-03 |
Hayashibara Co., Ltd. |
Skin-exterior anti-ageing composition and production method therefor
|
|
WO2014116985A1
(en)
|
2013-01-25 |
2014-07-31 |
Winning The Fight Inc. |
Composition for treatment of neurodegenerative disease
|
|
US9511057B2
(en)
|
2013-03-15 |
2016-12-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for treating denervation-induced muscle atrophy
|
|
BR112015024186B1
(pt)
|
2013-03-19 |
2023-05-09 |
University Of South Florida |
Composições e métodos para produção de cetose de elevação e manutenção
|
|
US20160263092A1
(en)
|
2013-12-19 |
2016-09-15 |
Twi Biotechnology, Inc. |
Therapeutic uses of berberine formulations
|
|
CN113082009A
(zh)
|
2014-02-12 |
2021-07-09 |
加利福尼亚大学董事会 |
用于治疗衰老和与年龄相关的疾病和症状的组合物和方法
|
|
WO2015171723A1
(en)
|
2014-05-06 |
2015-11-12 |
Research Development Foundation |
Methods for treating insulin resistance and for sensitizing patients to glp1 agonist therapy
|
|
KR102596106B1
(ko)
|
2014-06-30 |
2023-10-30 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
연령-관련 증상 및 질환의 치료를 위한 케토부티레이트 화합물 및 조성물
|
|
KR20250008786A
(ko)
|
2014-07-29 |
2025-01-15 |
센젠 하이타이드 바이오파마슈티컬 리미티드 |
베르베린 염, 우르소데옥시콜산 염 및 병용물, 이들의 제조 및 응용 방법
|
|
WO2016019224A1
(en)
|
2014-07-31 |
2016-02-04 |
Indiana University Research And Technology Corporation |
Antithetical regulation of endothelial ace and ace2 by brg1-foxm1 complex underlies pathological cardiac hypertrophy
|
|
CN104529755B
(zh)
*
|
2014-12-29 |
2016-01-06 |
精晶药业股份有限公司 |
一种从转化液中分离α-酮戊二酸的方法
|
|
US20180050048A1
(en)
|
2015-04-06 |
2018-02-22 |
SHENZHEN HJGHTIDE-BIOPHARMAGEUTiCAL, LTD. |
Conjugate compounds of ursodeoxycholic, berberine or l-carnitine, and compositions and methods thereof
|
|
CN107849083A
(zh)
|
2015-06-10 |
2018-03-27 |
益力舒健康公司 |
用于治疗皮肤病症的烟酰胺核苷和紫檀芪组合物和方法
|
|
WO2017008060A1
(en)
|
2015-07-08 |
2017-01-12 |
Unity Biotechnology, Inc. |
Compositions and methods for treating senescence-associated diseases and disorders
|
|
CN109803647A
(zh)
|
2016-09-30 |
2019-05-24 |
加州大学董事会 |
α-丁酮酸、α-酮戊二酸和2-羟基丁酸用于刺激毛发生长
|
|
PL231635B1
(pl)
|
2017-01-03 |
2019-03-29 |
Politechnika Poznanska |
Sposób produkcji kwasu alfa-ketoglutarowego (AKG) z jednoskładnikowych roztworów wodnych
|
|
MX2017004010A
(es)
|
2017-03-27 |
2018-02-09 |
Antonio Hernandez Miramontes Jorge |
Mezcla de oxalacetato, alfacetoglutarato, ácido tartánico y sales de lactato de calcio y sodio, para tratar pacientes con insuficiencia renal crónica.
|
|
CA3061381A1
(en)
|
2017-04-25 |
2018-11-01 |
Buck Institute For Research On Aging |
COMPOSITIONS COMPRISING α-KETOGLUTARATE FOR EXTENDING LIFESPAN AND HEALTHSPAN
|
|
WO2019038655A1
(en)
|
2017-08-21 |
2019-02-28 |
The Regents Of The University Of California |
COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
|
|
CN112955139B
(zh)
|
2018-09-25 |
2025-04-18 |
庞塞迪利昂健康特定活动公司 |
用于制备α-酮戊二酸钙的方法
|
|
US20210369750A1
(en)
|
2018-10-24 |
2021-12-02 |
Ponce De Leon Health Designated Activity Company |
Nicotinamide riboside compositions for healthspan extension
|
|
CN114126599A
(zh)
|
2019-06-10 |
2022-03-01 |
巴克老龄化研究所 |
改变衰老相关分泌表型的方法和组合物
|
|
TWI869410B
(zh)
*
|
2019-06-10 |
2025-01-11 |
愛爾蘭商龐賽德萊昂健康公司 |
α-酮戊二酸鹽之持續釋放組合物
|
|
EP4175978A4
(en)
|
2020-07-02 |
2024-06-26 |
Ponce de Leon Health Designated Activity Company |
COMPOSITIONS AND METHODS FOR TREATING CRP-MEDIATED DISEASES
|
|
CN112941116B
(zh)
*
|
2021-01-04 |
2022-12-02 |
上海朴颐化学科技有限公司 |
一种酶法制备α-酮戊二酸钙的方法
|
|
CN115974679A
(zh)
*
|
2022-12-20 |
2023-04-18 |
绍兴市精益生物化工有限公司 |
α-酮戊二酸钙盐制备方法
|